SRPT
Sarepta Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -7.1% ·
Aktienfluss +7.4% ·
neue Nettopositionen -7.7%
— Formel
Konzentrierte Akkumulation — steigende Anteile bei weniger Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q1 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 110 | +2 | 83.40M | $1.50B | +14 | −12 |
| Q1 2026 | 111 | +1 | 76.41M | $1.66B | +6 | −6 |
| Q4 2025 | 110 | +2 | 75.97M | $1.63B | +3 | — |
| Q3 2025 | 17 | 0 | 44.07M | $848.49M | +2 | −3 |
| Q2 2025 | 15 | -1 | 40.14M | $686.46M | +1 | −2 |
| Q1 2025 | 13 | -1 | 11.03M | $703.96M | +1 | −2 |
| Q4 2024 | 14 | -1 | 10.27M | $1.25B | +2 | −3 |
| Q3 2024 | 14 | +1 | 7.65M | $955.24M | +1 | — |
| Q2 2024 | 13 | — | 7.85M | $1.24B | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passiv) | 4.07M | 0.0% | $259.65M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 2.65M | +27.9% | $168.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Wellington Management ✦ | 2.65M | +27.9% | $168.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.65M | +27.9% | $168.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.65M | +27.9% | $168.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 2.65M | +27.9% | $168.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 2.65M | +27.9% | $168.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Wellington Management ✦ | 2.65M | +27.9% | $168.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Wellington Management ✦ | 2.65M | +27.9% | $168.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passiv) | 1.82M | +6.7% | $116.24M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Geode Capital Management ✦ (passiv) | 1.82M | +6.7% | $116.24M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | Norges Bank ✦ (passiv) | 1.19M | +14.8% | $76.10M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 550.88K | +634.0% | $35.16M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 238.25K | -1.4% | $15.21M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 238.25K | -1.4% | $15.21M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 235.79K | -61.8% | $15.05M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 235.79K | -61.8% | $15.05M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | Millennium Management ✦ | 206.94K | +1491.6% | $13.21M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | Marshall Wace ✦ | 27.20K | Neu | $1.74M | 0.0% | New | 1 | SEC ↗ |
| 20 | Marshall Wace ✦ | 27.20K | Neu | $1.74M | 0.0% | New | 1 | SEC ↗ |
| 21 | Bridgewater Associates ✦ | 19.82K | +277.9% | $1.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | Fisher Asset Management ✦ | 12.76K | -28.7% | $814,342 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 5.38K | +214.2% | $343,671 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 5.38K | +214.2% | $343,671 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 5.38K | +214.2% | $343,671 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 5.38K | +214.2% | $343,671 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 5.38K | +214.2% | $343,671 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 28 | D. E. Shaw & Co. ✦ | 4.41K | +25.9% | $281,191 | 0.0% | ▲ Add | 4 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Marshall Wace | $1.74M | 0.0% |
| Marshall Wace | $1.74M | 0.0% |
Ausgestiegen
| Soros Fund Management | $28.07M | war 0.7% |
| Adage Capital Partners | $21.28M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 339 Inhaber, 102.41M Anteile, $2.16B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.